13F 机构持仓

STEMPOINT CAPITAL LP

NEW YORK NY · SEC CIK 0001952142

2026Q22026Q1 更早 9 个季度 🔒
$5.81亿2026Q2 申报市值
84持仓数
41.0%前十大占比 · 第一大 6.6%
32 / 32新建仓 / 清仓
申报市值走势$5.81亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

TNGX 6.6%
ABVX 6.5%
RVMD 5.2%
ERAS 4.9%
TYRA 3.5%
DNTH 3.4%
ELVN 3.0%
MLYS 2.8%
BHVN 2.7%
SRZN 2.4%

2026Q2 买入最多 按季末市值估算

TNGX 加仓+$2,567.01万
ERAS 加仓+$1,989.90万
KNSA 新建仓+$1,338.05万
TRAX 新建仓+$1,252.92万
ORKA 新建仓+$1,108.36万

2026Q2 卖出最多 按季末市值估算

SRRK 减仓-$1.01亿
RVMD 减仓-$7,553.40万
SNDX 清仓-$5,679.95万
IMVT 减仓-$4,687.02万
ABVX 减仓-$4,583.14万

2026Q2 持仓明细 点表头排序 · 每页 100 行

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
ROIV ROIVANT SCIENCES LTD $1,233.02万2.12%348,408 -423,192-54.8% -$1,497.68万 减仓
PRAX PRAXIS PRECISION MEDICINES I $1,246.86万2.15%37,243 -75,291-66.9% -$2,520.67万 减仓
TRAX FIRST TRACKS BIOTHERAPEUTICS $1,252.92万2.16%622,723 622,723— $1,252.92万 新建仓
ALKS ALKERMES PLC $1,299.47万2.24%248,015 87,03154.1% $456.00万 加仓
SRRK SCHOLAR ROCK HLDG CORP $1,315.30万2.27%239,146 -1,831,846-88.5% -$1.01亿 减仓
KNSA KINIKSA PHARMACEUTICALS INTL $1,338.05万2.30%209,234 209,234— $1,338.05万 新建仓
SRZN SURROZEN INC $1,378.66万2.37%602,798 -118,822-16.5% -$271.76万 减仓
BHVN BIOHAVEN LTD $1,583.53万2.73%1,064,200 -2,124,782-66.6% -$3,161.68万 减仓
MLYS MINERALYS THERAPEUTICS INC $1,626.05万2.80%602,686 -464,070-43.5% -$1,252.06万 减仓
ELVN ENLIVEN THERAPEUTICS INC $1,760.59万3.03%346,914 -379,962-52.3% -$1,928.31万 减仓
DNTH DIANTHUS THERAPEUTICS INC $1,957.90万3.37%200,851 29,84717.5% $290.95万 加仓
TYRA TYRA BIOSCIENCES INC $2,021.02万3.48%632,754 246,40063.8% $787.00万 加仓
ERAS ERASCA INC $2,868.75万4.94%1,565,913 1,086,191226.4% $1,989.90万 加仓
RVMD REVOLUTION MEDICINES INC $2,995.41万5.16%159,943 -403,321-71.6% -$7,553.40万 减仓
ABVX ABIVAX SA $3,780.01万6.51%283,657 -343,925-54.8% -$4,583.14万 减仓
TNGX TANGO THERAPEUTICS INC $3,823.16万6.58%1,223,019 821,181204.4% $2,567.01万 加仓